CoreWeave’s $5 Billion Core Scientific Acquisition Faces Mounting Shareholder Opposition
CoreWeave’s ambitious $5 billion acquisition of Core Scientific faces mounting opposition from major shareholders ahead of a critical October 30 vote. Gullane Capital, the third-largest shareholder, has joined other investors in rejecting the current terms, citing valuation concerns and structural issues with the stock conversion deal.
Major Shareholder Joins Opposition to CoreWeave’s Acquisition Plan
A $5 billion merger crucial to CoreWeave‘s expansion in the artificial intelligence sector faces increasing uncertainty as another major investor has announced opposition to the deal. According to reports, Trip Miller, founder of Gullane Capital and the third-largest shareholder in Core Scientific, stated he would vote against the proposed acquisition by rival data center firm CoreWeave.
